Granahan Investment Management - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 173 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2021. The put-call ratio across all filers is 4.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q3 2021$2,954,000
-27.7%
44,467
-15.1%
0.06%
-26.3%
Q2 2021$4,084,000
-12.6%
52,351
+5.9%
0.08%
-23.2%
Q1 2021$4,674,000
-55.5%
49,413
-42.7%
0.10%
-58.1%
Q4 2020$10,515,000
+26.7%
86,294
-9.1%
0.24%
-16.3%
Q3 2020$8,296,00094,9640.28%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q4 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,737,297$176,802,0006.75%
MPM BioImpact LLC 308,686$19,938,0005.30%
Burrage Capital Management LLC 77,172$4,985,0003.49%
Orbimed Advisors 2,745,327$177,321,0002.50%
Parkman Healthcare Partners LLC 110,318$7,125,0002.01%
SECTORAL ASSET MANAGEMENT INC 284,486$18,375,0001.69%
First Light Asset Management, LLC 192,829$12,455,0001.45%
Asymmetry Capital Management, L.P. 22,608$1,460,0001.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,000$2,236,0000.74%
Prosight Management, LP 25,602$1,654,0000.71%
View complete list of TURNING POINT THERAPEUTICS I shareholders